Stock Taper
SCREENER COMPARE ANY 2 STOCKS
MNOV
MEDICINOVA, INC.
NASDAQ
$1.44
▲ UP 1.06% (0.01)

KEY STATISTICS

Market Cap$70.63 M
52w High$1.96
52w Low$1.17
Dividend Yield—
Frequency—
P/E-6.83
Volume16.89K
Shares Out.49.22M

COMPANY

LEADERSHIP

Yuichi Iwaki
CHIEF EXECUTIVE
Yuichi Iwaki

COMPENSATION 2026

Salary$657,377
Stock Awards$0
Incentive Plan Pay$328,689
All Other Comp.$21,000
Total$1,736,711

ABOUT

SECTOR
Healthcare
WENT PUBLIC
December 8, 2006
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
6

UPCOMING EARNINGS

DateNov 12, 2026
DayThursday
Rev. Est.$75.00K
NOV
12
THU

PRICE

$1.44 ▲ UP 1.06% (+$0.01)
$1.43$1.43$1.449:44 AM10:45 AM11:46 AM12:47 PM1:48 PM2:49 PM3:50 PM1.44

About MediciNova, Inc.

https://www.medicinova.com ↗

MediciNova, Inc. develops novel small molecule therapeutics for serious unmet medical needs, targeting neurological, fibrotic, and cancer diseases with products like MN-166 and collaborations with multiple pharmaceutical companies.

INDUSTRY

Biotechnology

A PRODUCT MEDICINOVA, INC. IS KNOWN FOR

MN-166 (ibudilast)
MN-166 (ibudilast)

MediciNova's leading clinical-stage oral small molecule drug candidate is being developed for neurological disorders like ALS and MS.

COMPETITORS

COMPETITOR
ALEC COMPARE
AMLX COMPARE
BCLI COMPARE
BIIB COMPARE
TGTX COMPARE

ETFS HOLDING THIS STOCK

ETFS HOLDING
2
LISTED HERE
2
RANKED BY POSITION SIZE
VXF
0.00% · 609.1K
IWC
0.02% · 161.1K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
14.26%
HOLDERS
48
TOP 12 OF 48 · RANKED BY POSITION SIZE
Blackrock Fund Advisors
1.4M sh · $8.58M
Essex Woodlands Management, Inc.
1.1M sh · $1.45M
Blackrock, Inc.
706.0K sh · $967.16K
Vanguard Group Inc
705.6K sh · $924.37K
Blackrock Inc.
694.9K sh · $1M
Citigroup Inc
635.7K sh · $870.93K
Geode Capital Management, LLC
543.8K sh · $745.25K
Blackrock Institutional Trust Company, N.A.
422.2K sh · $2.55M
Ubs Group AG
225.7K sh · $295.62K
Renaissance Technologies LLC
196.8K sh · $257.81K
State Street Corp
193.7K sh · $265.37K
Jane Street Group, LLC
163.1K sh · $213.66K

RATINGS SNAPSHOT

Overall rating: C+

DCFROEROAD/EP/EP/B
Discounted Cash Flow3
Return On Equity1
Return On Assets1
Debt To Equity4
Price To Earnings1
Price To Book3
Overall Score2

INSIDER TRADES

★
DIRECTOR
Nagao Hideki
Purchase · 44.5K shares
2026-06-23
★
DIRECTOR
Lemerond Nicole
Purchase · 44.5K shares
2026-06-23
★
DIRECTOR
BEAVER CAROLYN
Purchase · 44.5K shares
2026-06-23
★
OFFICER: CHIEF MEDICAL OFFICER
Matsuda Kazuko
Purchase · 350.0K shares
2026-01-16

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 1
1 GRADES IN THE LAST 12 MONTHS
D. Boral Capital BUY

SECTORS PEERS

PEERPRICE
RLMD$4.33COMPARE
IMUX$15.40COMPARE
CBUS$1.65COMPARE
BMEA$1.73COMPARE
VXRT$0.50COMPARE
FBIO$2.77COMPARE
ACRV$2.06COMPARE
XBIT$2.27COMPARE